In adulthood the hypothalamo-pituitary-adrenal axis is controlled by both CRH and arginine vasopressin (AVP). However, in neonates CRH secretion is very low, whereas AVP secretion is fully functional. This suggests that the role of AVP is more pronounced in young than in adult rats. We investigated the role of AVP by studying stress responses in 5, 10, and 20-d-old AVP-deficient Brattleboro rats. Two different stressors were applied: 24-h maternal separation and Hypnorm Grove Oxford UK injections. In heterozygous controls (that do express AVP), both stressors increased plasma ACTH and corticosterone. The ACTH stress response disappeared in AVPdeficient rats, demonstrating that during the perinatal period, the secretion of this hormone is controlled by AVP. Surprisingly, corticosterone responses remained intact in AVP-deficient rats. Similar findings were obtained after 1-, 4-, 12-, and 24-h long maternal separations. Thus, preserved corticosterone stress responses were not explained by changes in the timing of ACTH secretion. In vitro experiments suggested that the dissociation of ACTH and corticosterone stress responses can only be partly explained by higher ACTH responsiveness of the adrenal cortex in AVP-deficient rats. Together, our results show that in neonatal periods, AVP is crucial for the expression of ACTH stress responses, but neither AVP nor ACTH is necessary for the induction of corticosterone stress responses. Discrepant ACTH and corticosterone stress responses may reflect compensatory mechanisms activated by AVP deficiency, but disparate findings suggest that they rather depict a neonate-specific mechanism of hypothalamo-pituitary-adrenal-axis control. (Endocrinology 149: 2576 -2583, 2008) I N ADULT RATS, two neuropeptides, CRH and arginine vasopressin (AVP) from the nucleus paraventricularis hypothalami (PVN), control the ACTH release in the anterior pituitary. The relative contributions of CRH and AVP to ACTH release seem to be stressor specific (1); however, there is a consensus that in adulthood, the release is controlled mainly by CRH, whereas AVP only supports its effect (2). Less is known about the regulation of the hypothalamopituitary-adrenal (HPA) axis during development. In rats, the HPA axis is already functional in late gestation. As a consequence, high plasma corticosterone (B) levels can be seen during the late gestation and after birth. However, plasma levels decrease dramatically during the first 2 postnatal days and remain low until postnatal d 14 (3, 4). During this period, the response of the HPA axis to stressful stimuli (e.g. exposure to ether vapors or cold, endotoxin injection, maternal deprivation, or electroshocks) is markedly reduced compared with the large responses seen in adult rats (5). This stress hyporesponsive (SHRP) period was demonstrated in both rat pups and children, and has major implications for the maturation of the HPA axis (5-7). Mechanisms underlying stress hyporesponsiveness are not fully understood. It was assumed that it is mainly related to enhanced negative feedback at the pituitary level, which is probably due to low transcortin levels (5, 8, 9). Alternatively, or in addition, the diminished production and/or transport of hypothalamic secretagogues may also decrease B-stress responses (10). The latter assumption is supported by the fact that the glucocorticoid regulation of hypothalamic CRH gene expression is not mature in the SHRP period (11). In contrast, the regulation of hypothalamic AVP gene expression matures very early (11, 12) . Thus, AVP may be the major factor that controls ACTH release during the stress-hyporesponsive period (13, 14) .
I
N ADULT RATS, two neuropeptides, CRH and arginine vasopressin (AVP) from the nucleus paraventricularis hypothalami (PVN), control the ACTH release in the anterior pituitary. The relative contributions of CRH and AVP to ACTH release seem to be stressor specific (1); however, there is a consensus that in adulthood, the release is controlled mainly by CRH, whereas AVP only supports its effect (2) . Less is known about the regulation of the hypothalamopituitary-adrenal (HPA) axis during development. In rats, the HPA axis is already functional in late gestation. As a consequence, high plasma corticosterone (B) levels can be seen during the late gestation and after birth. However, plasma levels decrease dramatically during the first 2 postnatal days and remain low until postnatal d 14 (3, 4) . During this period, the response of the HPA axis to stressful stimuli (e.g. exposure to ether vapors or cold, endotoxin injection, maternal deprivation, or electroshocks) is markedly reduced compared with the large responses seen in adult rats (5) . This stress hyporesponsive (SHRP) period was demonstrated in both rat pups and children, and has major implications for the maturation of the HPA axis (5) (6) (7) . Mechanisms underlying stress hyporesponsiveness are not fully understood. It was assumed that it is mainly related to enhanced negative feedback at the pituitary level, which is probably due to low transcortin levels (5, 8, 9) . Alternatively, or in addition, the diminished production and/or transport of hypothalamic secretagogues may also decrease B-stress responses (10) . The latter assumption is supported by the fact that the glucocorticoid regulation of hypothalamic CRH gene expression is not mature in the SHRP period (11) . In contrast, the regulation of hypothalamic AVP gene expression matures very early (11, 12) . Thus, AVP may be the major factor that controls ACTH release during the stress-hyporesponsive period (13, 14) .
The role of AVP was studied here using the AVP-deficient Brattleboro rat. This strain was discovered in the mid-60s and shows an inherited single nucleotide deletion at the neurophysin II region of the AVP precursor molecule, which results in an abnormal AVP prohormone. This is not processed normally, and consequently, rats lack functional AVP and show diabetes insipidus (15) . The aim of the present experiments was to investigate stress responses in young rats belonging to the AVP-deficient strain. Brattleboro rats heterozygous for the mutant gene were used as comparisons (16) . only, they produce large amounts of AVP shortly after birth and do not show diabetes insipidus. Pups were produced by a parent stock obtained from Harlan Laboratories (Indianapolis, IN). Parents and pups were kept under specific pathogen-free conditions in a controlled environment (temperature: 23 Ϯ 1 C; relative humidity: 50 -70%). The day/night schedule was 12/12 h, with lights on at 0700 h. Parents were fed on a commercial rat chow (Charles River Laboratories, Budapest, Hungary) and had free access to tap water. Breeding pairs consisted of a di/ϩ female and a di/di male. The advantages of this breeding scheme were outlined elsewhere (17) . We ran a series of preliminary experiments in which litter size was controlled to six in a subgroup of dams. We found that litter size did not affect the findings. Therefore, the studies presented here were done in litters uncontrolled for size.
Experiments were performed in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC), and were reviewed and approved by the Animal Welfare Committee of the Institute of Experimental Medicine.
Experimental design
A total of seven experiments was performed, each being started in the morning between 0900 and 1200 h. Treatments were balanced over litters blindly, and data obtained in the two genders were pooled. The genotype of pups was established at the end of all experiments by measuring pituitary AVP content by RIA (see below).
In experiment 1 we investigated the effect of 24-h long maternal deprivation on brain CRH mRNA, as well as on plasma ACTH and B levels in 9-d-old pups. In each litter, half of the pups were separated from their mother, whereas the other half remained undisturbed. During maternal deprivation, littermates were kept together in a novel cage with normal bedding. No additional treatment was provided. All pups were killed by decapitation on d 10, with ACTH and B levels being determined in trunk blood. Brains were collected on dry ice (n ϭ 14 -48 per group).
Experiment 2 assessed the time course of ACTH and B responses. Pups were separated from their mother as described for experiment 1 but were killed 1, 4, 12, and 24 h after separation. Undisturbed littermates were used as comparisons. Separate litters were used for each time point. To avoid extensive overlap of data points, the data are expressed as increments from the control values; we subtracted the mean of the respective controls from the value of each animal. Control values are presented in Table 1 . The 24-h deprivation was studied again to evaluate the replicability of the effects seen in experiment 1 (n ϭ 16 -32 per group).
Experiment 3 explored the age dependence of the maternal separation effects. In this experiment, 4, 9, and 19-d-old rats were submitted to maternal deprivation. One day (24 h) later (i.e. at the age of 5, 10, and 20 d), trunk blood was collected for hormone measurements. The 10-d-old group was included again for comparison to the results seen in experiment 1 (n ϭ 26 -31).
In experiment 4, we investigated the effect of a different stressful stimulus on HPA-axis responsiveness. The 10-d-old pups were injected sc with 1 l/g fentanyl-fluanisone combination (Hypnorm; Janssen Pharmaceuticals, Grove, Oxford, UK), which is a widely used anesthetic; furthermore, one of the components, the -opiate agonist fentanyl, is commonly used in pediatric surgery. We demonstrated earlier that Hypnorm effectively activates the HPA axis in 10-d-old pups (18) . Controls received saline. After injections, pups were returned to the dams, and trunk blood was collected for hormone measurements 60 min later. The Hypnorm dose and the timing of decapitation were selected based on a previous study (18) (n ϭ 32-46). Experiment 5 assessed the age dependence of the Hypnorm effect. To exclude the possibility that corticosterone increased in response to an earlier ACTH increase, the 5-, 10-, and 20-d-old pups were decapitated 30 min after the sc injection of 1 l/g Hypnorm (n ϭ 14 -20) .
In experiment 6, we investigated the possibility that the discrepant ACTH/B secretion patterns seen in the former experiments were due to an altered responsiveness of the adrenal cortex to ACTH. The adrenal glands were sampled from 10-d-old pups, dissected into four pieces, and incubated in vitro in 1 ml DMEM [Sigma-Aldrich, Budapest, Hungary (pH 7.4)] containing 2.5% BSA at 37 C in a 95% O 2 -5% CO 2 atmosphere (one gland per tube). After 60 min the buffer was replaced with fresh DMEM, and the adrenals were preincubated for a further 60 min, then 15-min samples were collected six times with ACTH-containing (10 Ϫ13 m, 10 Ϫ12 m, or 10 Ϫ11 m; Sigma-Aldrich) medium in the second fraction. At the end of each 15-min incubation period, the medium was aspired, centrifuged, and the supernatant was kept at Ϫ20 C for B determination. To avoid confounds from the preparation-induced differences, all data were expressed as percentage of the basal secretion measured in the first 15-min sample (n ϭ 8 -15).
Experiment 7 aimed at evaluating the in vivo relevance of data obtained in experiment 6. In this experiment, 10-d-old pups received a sc injection of 250 ng ␤1-24-corticotrophin (Synacthen; CIBA, Baden, Switzerland) per g body weight. After injections, pups were returned to their mothers and were decapitated 60 min later when blood was collected for hormone measurements (n ϭ 33-46). Dosage was based on preliminary experiments performed in 10-d-old Wistar rats. In these preliminary experiments, low doses of Synacthen (2, 10, and 50 ng/g) had no significant effect on ACTH plasma levels 15 min after injections. In contrast, the 250 ng/g dose induced a 2.5-fold ACTH increase at 15 min and a 2-fold increase at 30 min. Values returned to control levels after 60 min. Plasma B was 1.6-, 2.3-and 3-fold, higher 15, 30, and 60 min after injections, respectively. We did not study the effect of even larger Synacthen doses for two reasons. First, changes in sensitivity are more evident at low than at higher doses because large doses may overrun small differences in sensitivity. Second, in accordance with the aforementioned argument, the findings of experiment 6 showed that the perceived sensitivity of the adrenals to ACTH correlated inversely with the dose, i.e. the impact of sensitivity on B secretion decreased at higher doses.
Hormone assays
Blood was collected on ice-cold Eppendorf tubes containing 20 l 20% sodium-EDTA and centrifuged at 3000 rpm/min for 20 min at Ϫ4 C. The plasma was stored at Ϫ20 C till the hormone assays. Plasma ACTH was measured by RIA in 50 l unextracted plasma as described earlier (19) . The ACTH antibody was raised in rabbit in the Institute of Experimental Hormonal responses to maternal separation were shown in Fig. 2 as a change from these control values. Under resting conditions, hormone levels did not change over the investigated period (postnatal d 9 -10). Plasma corticosterone was higher in di/di as compared with di/ϩ pups throughout.
Medicine, Hungarian Academy of Sciences (Budapest, Hungary) and was directed against the middle part of the h-ACTH 1-39 molecule. The sample no. 8514 was used. The antibody is highly specific, showing 0.2% cross-reaction with ␣-MSH, and no significant cross-reaction with ␥-MSH, corticotropin-like intermediate lobe peptide, ACTH [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , ACTH [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] , ACTH [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , and ACTH [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Yet, the synthetic ACTH was fully recognized. The intraassay coefficient of variation was 7.23%. All the samples from a particular experiment were assessed in the same RIA. Plasma B was measured in 10 l unextracted plasma by a RIA using a specific antibody developed in our institute as described earlier (20) . The B antibody was raised in rabbits against B-carboxymethyloxime BSA.
125 I-labeled B-carboxymethyloxime-tyrosine methyl ester was used as tracer. The interference from plasma transcortin was eliminated by inactivating transcortin at a low pH. Assay sensitivity was 1 pmol. The intraassay coefficient of variation was 7.5%. All the samples from a particular experiment were measured in one RIA.
Pups were genotyped by measuring the hypophyseal AVP content. Pituitaries were sampled on 100 l 0.1 n HCl and were frozen toϪ20 C. After thawing, pituitaries were boiled for 5 min, after which they were ultrasonically homogenized, and the AVP content of the 100-times diluted homogenate was measured. The rabbit AVP antiserum was obtained from Dr. M. Vecsernyés (Szent-Gyö rgyi Medical University, Szeged, Hungary). The intraassay and interassay coefficients of variation were 10.7 and 17.7%, respectively.
In situ hybridization
Frozen forebrains were mounted on a cryostat microtome and cut into 16-m coronal sections. Every sixth section was mounted on a silanized slide. The hybridization technique was similar to that described by Simmons et al (21) and used earlier in our laboratory (22) .
CRH mRNA levels were quantified by [ 35 S]uridine 5Ј-triphosphate containing riboprobes complementary to exonic sequences of the CRH gene; the plasmid containing the 1.2-kb template was a generous gift of Dr. K. Mayo (Northwestern University, Evanston, IL). After the hybridization process, slides were exposed to imaging plates (Fujifilm, BAS-IP, MS 2340; Fujifilm Corp., Tokyo, Japan) for 72 h, and the plates were scanned by a fluorescent image analyzer (FLA 3000, scanning resolution of 50 m; Fujifilm). Radiograms were evaluated using the public domain ImageJ program (Bethesda, MD) (written by Wayne Rasband at National Institutes of Health and available from the Internet by anonymous ftp from zippy.nimh.nih.gov). The boundary of the examined region was outlined, and the average grayness value was corrected by the background taken from neighboring hypothalamic tissue.
Statistical analysis
Statistical analysis was performed using the STATISTICA 6.0 Software (StatSoft, Inc., Tulsa, OK). Data (expressed as means Ϯ sem) were analyzed by factorial ANOVA. The Newman-Keuls test was used for post hoc comparisons. P Ͻ 0.05 was considered statistically significant.
Results

Genotyping
Genotyping was made indirectly by measuring the AVP content of the pituitaries (Table 2) . Pups were assigned to the di/di genotype if the AVP content was below or close to detection limits independently of maternal deprivation. Pups showing detectable AVP levels were assigned to the di/ϩ group. The average AVP level in these pups was about 100-fold higher than those found in pups assigned to the di/di group (effect of genotype: F (1,289) ϭ 534.6, P Ͻ 0.01). It is noteworthy that AVP levels increased in di/ϩ pups between postnatal d 5 and 10, whereas in later life, it remained stable (age ϫ genotype interaction: F (2,289) ϭ 45.1, P Ͻ 0.01).
HPA-axis responses to 24-h maternal deprivation in 10-d-old pups (experiment 1)
Maternal separation for 24 h was unable to induce any changes in the CRH mRNA levels ( Fig. 1A ; effect of sepa- Data were presented also in Fig. 3 . Yet, the large stress responses, and the resulting y-axis scale, make small differences hard to follow on the figure. As seen in this Table, the plasma levels of both hormones increased with age. Plasma corticosterone levels were increased in di/di pups as compared with di/ϩ controls at 10 d. This variable was used to genotype the pups. The AVP content of the whole pituitary was measured from homogenized tissue by RIA. In di/di animals the levels were below the detection limit (n ϭ 26 -31).
a P Ͻ 0.01 vs.
ration was not significant: P ϭ 0.32). The lack of AVP significantly diminished CRH mRNA levels (effect of genotype: F (1,35) ϭ 14.9, P Ͻ 0.01).
In control (di/ϩ) pups, maternal separation for 24 h resulted in approximately 2-fold elevation of plasma ACTH levels ( Fig. 1B ; effect of separation: F (1,128) ϭ 13.7, P Ͻ 0.01). The undisturbed 10-d-old di/di pups had ACTH hormone levels similar to their di/ϩ littermates, but the 24-h separation period did not change their ACTH levels (effect of genotype: F (1,128) ϭ 27.6, P Ͻ 0.01; as well as genotype ϫ separation interaction: F (1,128) ϭ 25.1, P Ͻ 0.01).
The plasma B levels were elevated 5-to 6-fold at the end of the 24-h separation period in di/ϩ animals ( Fig. 1C ; effect of separation: F (1, 128) ϭ 355.7, P Ͻ 0.01). The AVP-deficient, undisturbed 10-d-old pups showed significantly higher resting B levels (effect of genotype: F (1,128) ϭ 13.9, P Ͻ 0.01). Separating the di/di offspring from their mother for 24 h resulted in further B elevation above the levels found in di/ϩ rats (no genotype ϫ separation interaction).
Time course of HPA-axis responses in 10-d-old pups (experiment 2)
In control di/ϩ rat pups, plasma ACTH levels showed a small but significant elevation as a result of separation at all time points ( Fig. 2A ; effect of separation: F (1,355) ϭ 15.2, P Ͻ 0.01), the highest level being seen after 24 h (effect of time: F (3,355) ϭ 3.5, P ϭ 0.015); at 24 h the elevation was 2-fold, whereas at other time points approximately 1.5-fold. In undisturbed pups, there was no difference in plasma ACTH levels between the genotypes (Table 1 ; effect of genotype: P ϭ 0.14; time ϫ genotype: P ϭ 0.37). In di/di rats, the ACTH levels did not change after separation ( Fig. 2A ; separation ϫ genotype: F (1,355) ϭ 15.1, P Ͻ 0.01).
The separation induced a significant B elevation ( Fig. 2B;  F (1,356) ϭ 408.3, P Ͻ 0.01). In the control, di/ϩ rat pups, the increase was approximately 2-fold at 1 and 4 h, and a gradual further increase occurred till the end of 24-h examination period (up to 7-fold at 24 h). The undisturbed di/di offspring had higher B-plasma levels during the whole examination period (Table 1 ; effect of genotype: F (1, 356) ϭ 242.9, P Ͻ 0.01). The maternal separation-induced B elevation was significantly larger in di/di than in di/ϩ littermates, starting from 4 h after separation ( Table 1 (n ϭ 16 -32). *, P Ͻ 0.05; **, P Ͻ 0.01 vs. undisturbed control. ##, P Ͻ 0.01 vs. di/ϩ pups.
40.6, P Ͻ 0.01), suggesting that the effect of the AVP deficiency was synergistic with the separation-induced B increase.
Developmental effects (experiment 3)
The resting ACTH levels increased between postnatal d 5 and 10 in both genotypes (Table 3 ; effect of age: F (2,290) ϭ 18.5, P Ͻ 0.01). Maternal separation of 24 h significantly increased plasma ACTH in di/ϩ pups at all three ages; the lowest increase was at 5 d ( Fig. 3A ; effect of maternal separation: F (1,290) ϭ 37.2, P Ͻ 0.01). No similar changes were noticed in di/di pups (effect of genotype: F (1,290) ϭ 16.4, P Ͻ 0.01).
The resting plasma B level increased gradually with age and was always higher in AVP-deficient pups (Table 3 ; effect of age: F (2,157) ϭ 56.4, P Ͻ 0.01; effect of genotype: F (1,157) ϭ 12.3, P Ͻ 0.01). Maternal deprivation increased plasma B in both di/ϩ and di/di pups (no significant genotype effect: P ϭ 0.13), the highest increase being seen at 10 d (Fig. 3B ; effect of maternal separation: F (1, 290) ϭ 98.0, P Ͻ 0.01; age: F (2,290) ϭ 36.2, P Ͻ 0.01; and separation ϫ age interaction: F (2,290) ϭ 5.87, P Ͻ 0.01).
Effect of Hypnorm (experiment 4)
In di/ϩ pups, Hypnorm administration to 10-d-old pups increased plasma ACTH levels 6-fold within 60 min ( Fig. 4A ; effect of treatment: F (1, 164) ϭ 88.3, P Ͻ 0.01). The AVP deficiency did not influence the resting ACTH levels but abolished the Hypnorm-induced elevation (effect of genotype: F (1, 164) ϭ 57.0, P Ͻ 0.01; and genotype ϫ treatment interaction: F (1, 164) ϭ 54.7, P Ͻ 0.01).
At 60 min, Hypnorm increased plasma B by 2.4-fold in di/ϩ pups ( Fig. 4B; F (1,163) ϭ 134.5, P Ͻ 0.01). The resting B levels were elevated in di/di pups (effect of genotype: F (1, 163) ϭ 72.1, P Ͻ 0.01), but the Hypnorm treatment was able to induce a further increase (no genotype ϫ treatment interaction: P ϭ 0.26).
Age-dependent effects of Hypnorm (experiment 5)
Hypnorm administration was able to induce a significant ACTH increase 30 min after its administration already in 5-d-old di/ϩ rats (ϳ10-fold), however, in 10-and 20-d old rats, this elevation was more pronounced approximately 50-fold (Fig. 4C , effect of treatment: F (1, 183) ϭ 224.9, P Ͻ 0.01; effect of age: F (2,183) ϭ 38.1, P Ͻ 0.01; treatment ϫ age interaction: F (2,183) ϭ 33.6, P Ͻ 0.01). In AVP-deficient pups, this elevation was significantly lower at each age (effect of genotype: F (1, 183) ϭ 106.9, P Ͻ 0.01; genotype ϫ treatment interaction: F (1, 183) ϭ 97.9, P Ͻ 0.01; genotype ϫ age interaction: F (2,183) ϭ 17.8, P Ͻ 0.01; genotype ϫ treatment ϫ age interaction: F (2,183) ϭ 16.9, P Ͻ 0.01).
Plasma B levels increased 2-fold in 5-and 10-d-old di/ϩ rats 30 min after sc Hypnorm injection, whereas in 20-d-old rats, this elevation went up to 3-fold (Fig. 4D ) (effect of age: F (2, 190) ϭ 820.5, P Ͻ 0.01; treatment: F (1, 190) ϭ 587.2, P Ͻ 0.01; age ϫ treatment interaction: F (2, 190) ϭ 331.8, P Ͻ 0.01). The AVP-deficient di/di pups showed a similar profile (no significant effect of genotype: P ϭ 0.09; genotype ϫ treatment: P ϭ 0.12; and genotype ϫ age ϫ treatment interaction: P ϭ 0.22).
ACTH-induced B responses in 10-d-old pups (Experiments 6 and 7)
Three doses of ACTH (10 Ϫ13 , 10 Ϫ12 , and 10 Ϫ11 m) dose dependently increased the area under the curve (23) of B secretion ( Fig. 5A ; effect of treatment: F (2,70) ϭ 10.5, P Ͻ 0.01). The increase was higher in di/di rats (effect of genotype: F (1,70) ϭ 9.7, P Ͻ 0.01). Yet, the difference was not significant at any time point in post hoc comparisons.
The lowest dose, which most likely reveals the enhancement in sensitivity, significantly elevated B secretion from the adrenal gland ( Fig. 5B ; effect of treatment: F (5,115) ϭ 21.7, P Ͻ 0.01). The increase was significantly larger in di/di pups 15 min after ACTH treatment, but not at other time points (effect of genotype ϫ treatment interaction: F (5,115) ϭ 2.4, P ϭ 0.042).
Synacthen did not increase ACTH levels in either genotype 60 min after its administration (data not shown). In contrast, plasma B levels were significantly increased in both di/ϩ and di/di pups ( Fig. 5C ; effect of genotype: F (1, 150) ϭ 68.7, P Ͻ 0.01; effect of treatment: F (1,150) ϭ 123.2, P Ͻ 0.01; interaction: F (1,150) ϭ 14.6, P Ͻ 0.01). As earlier, AVP-deficient di/di pups showed higher basal B levels. However, the ACTH-induced increase was similar in the two genotypes (plasma B was   FIG. 3 . The effect of 24-h maternal separation at different postnatal ages. At each age group, half of the pups was separated from their mother and decapitated together with their undisturbed littermates 24 h later. Maternal separation elevated plasma ACTH (A) in di/ϩ pups only, whereas plasma corticosterone (B) was elevated in both genotypes, the highest levels being seen at 10 d (n ϭ 25-29). *, P Ͻ 0.05; **, P Ͻ 0.01 vs. undisturbed control. #, P Ͻ 0.05; ##, P Ͻ 0.01 vs. di/ϩ pups. C, Control, undisturbed; S, decapitated after 24-h maternal separation.
increased by 153 Ϯ 20% and 162 Ϯ 12% in di/ϩ and di/di pups, respectively).
Discussion
Our results demonstrate that AVP deficiency abolishes ACTH stress responses in young rats. This suggests that in these rats, AVP is the key signal that controls ACTH release from the pituitary. However, B responses were not affected by AVP deficiency. Discrepant ACTH and B responses are not explained by a differential time course of the secretion of the two hormones, and are only partly explained by the altered ACTH sensitivity of the adrenals (see below).
We investigated HPA-axis activation in a period when it was initially thought to be unresponsive to stress (5, 24) . However, there are a series of studies showing that stress resistance is only relative in pups, and consequently, the terminology of the period was changed from "stress nonresponsive" to SHRP (2, 6). Our results show that the resting B levels are measurable, although small, during the whole neonatal period and increase approximately 3-fold to an adult-like level at d 20 (5, 23) . In line with these earlier findings, 24-h maternal separation and Hypnorm injections increased plasma ACTH and B in pups at all ages. In di/ϩ pups, the magnitude of the response increased with age, which could be explained by the maturation of the HPA axis (Figs. 3 and 4) .
In adult rats, acute stressful stimuli increase CRH mRNA levels in the PVN after 4 h, and the effect usually persists for 24 h (25) . CRH mRNA levels in the PVN were not increased in 10-d-old pups by maternal separation, supporting the views that CRH secretion is not mature, and AVP has a more prominent regulatory role at this age. The reduced resting CRH mRNA levels in di/di pups suggest a delay in the maturation of CRH secretion. This delay, together with the AVP deficiency, might explain the lack of ACTH responses to stressful stimuli in this genotype.
The lack of ACTH stress responses in AVP-deficient pups highlights the role of AVP in the control of ACTH secretion in the perinatal period (6) . In contrast to adult rats, in which CRH is the main pituitary secretagogue (26) , in young rats AVP is secreted in considerably larger amounts than CRH (6, 12) . The role of AVP appears to be limited to stress responses because basal ACTH levels were not affected by its absence. This conclusion is supported by earlier findings showing that the basal ACTH secretion is relatively independent of hypothalamic input during the SHRP (27) . The importance of AVP is also outlined by the fact that passive immunization to AVP in 8-d-old rats prevented the hypoglycemia-induced ACTH increase without affecting basal levels (12) . CRH immunization was ineffective. However, passive immunization against CRH abolished cold stress-induced B responses during the SHRP (28) , and the same treatment reduced the urethane administration-induced ACTH elevation (4) . One can hypothesize that the involvement of AVP is stressor specific (13, 29) . Our findings partly support this notion because no ACTH response was noticed in maternally deprived AVPdeficient rats, but in the same rats, a small ACTH activation was noticed after Hypnorm injections.
The most intriguing finding of the present study is the total dissociation of ACTH and B-stress responses in AVP-deficient Brattleboro pups. Normally, ACTH secretion precedes the secretion of B, and the secretion of the latter correlates with the secretion of the former. In contrast to this general picture, the ACTH response to maternal deprivation was absent in AVP-deficient rats, yet the increase in B levels was more pronounced. Our findings exclude the possibility that the discrepancy between ACTH and B production was due to a temporal dissociation between the two events. In pups lacking AVP, maternal deprivation increased plasma B gradually, whereas ACTH responses were absent throughout. This precludes that an early increase in ACTH prompted a delayed B response (i.e. an ACTH response that disappeared before the first hour of deprivation could not increase B production 24 h later). Somewhat similar findings were obtained by Walker et al. (29) , who have shown in 10-d-old Sprague Dawley rats that the B response was pronounced 8 and 12 h after maternal deprivation, but the increase in ACTH was small and only marginally significant during the investigated period. It was shown earlier that the adrenals are affected by the lack of feeding that is associated with maternal separation (13) . However, our results show that the dissociated ACTH and B-stress responses are not restricted to maternal separation because Hypnorm injections produced similar effects within 30 and 60 min. In such a short period, feeding could not affect the results. We note that all pups had unrestricted access to their dams in this paradigm.
One can hypothesize that the dissociation of ACTH and B-secretion patterns was explained by the increased ACTH sensitivity of the adrenals. Because AVP might inhibit ACTH/B-signal transduction (30) , increased adrenal sensitivity may result from the removal of this inhibitory effect in di/di pups. This phenomenon may be one of the mechanisms that increase the ACTH sensitivity of the adrenals in di/di pups. According to this scenario, a small increase in ACTH would result in a large B synthesis. In line with this assumption, the in vitro sensitivity of the adrenals to ACTH increased by 87.9% at 10 Ϫ13 m ACTH, 62.2% at 10 Ϫ12 m ACTH, and 57.6% at 10 Ϫ11 m ACTH. These figures derive from the comparison of B responses noticed in di/ϩ and di/di pups after the respective ACTH stimuli. The ACTH-induced increases in B secretion (expressed as percent change from baseline) were as follows: 1) at 10 Ϫ13 m ACTH: B secretion increased by 85.5% in di/ϩ pups, whereas the same figure was 158.9% in di/di pups; 2) at 10 Ϫ12 m ACTH: 206.5% in di/ϩ pups and 335.2% in di/di pups; and 3) at 10 Ϫ11 m ACTH: 212.4% in di/ϩ pups and 334.9% in di/di pups. Thus, the sensitivity of di/di adrenals increased at each ACTH dose.
However, the ACTH stress response was completely absent in maternally deprived rats; moreover, ACTH levels were even slightly (but not significantly) decreased toward the end of maternal deprivation. This renders the increase in adrenal sensitivity irrelevant in the case of this stress type. Although a mild ACTH response was noticed after Hypnorm injections in di/di pups, we suggest here that this cannot account for the largely discrepant ACTH and B-secretion patterns. In 10-d-old di/ϩ pups (the age at which we studied adrenal sensitivity), Hypnorm injections increased ACTH and B levels by 236.8 fmol and 132.7 pmol, respectively. Thus, each fmol of ACTH was associated with the secretion of 0.56 pmol of B. In di/di pups, Hypnorm injections increased ACTH and B levels by 28.2 fmol and 109.1 pmol, respectively. Thus, each femtomole of ACTH was associated with the secretion of 3.87 pmol of B in this genotype. Thus, the same amount of ACTH was associated with a 7-fold (690%) higher B secretion in di/di as compared with di/ϩ pups. Yet, the adrenal sensitivity of di/ϩ pups was increased by about 60 -90% only, depending on the dose of ACTH (see above).
Because in vitro preparations lack neural input that may adjust adrenal sensitivity (31), we tested also the in vivo adrenal sensitivity in which we failed to show increased sensitivity of the adrenal cortex to ACTH stimulation. In adults, even a reduced adrenal sensitivity of di/di Brattleboro adrenals was shown (32) . Together, these considerations show that the ACTH sensitivity of the adrenals does not explain discrepant ACTH and B-secretion patterns.
Dissociated ACTH and B-secretion patterns were reported in a number of earlier studies. Walker et al. (29) showed in Sprague Dawley rats that the B responses to maternal deprivation and hypoxia were not accompanied by increased ACTH secretion. Fetal sheep exposed to hypoxia also showed a robust B production without a parallel increase in ACTH (33) . In these animals the increase in plasma B depended on splanchnic innervation. These findings suggest that the B secretion is not or weakly dependent on ACTH at early ages. Recent findings suggest that the control of B secretion has a non-ACTH component in adult animals as well (34) . One can hypothesize that the relative importance of this component is much larger at early ages than in adulthood.
In summary, our findings show that AVP is necessary for the development of ACTH stress responses in neonates, but neither AVP nor ACTH is necessary for the development of B-stress responses. These findings suggest that the mechanisms underlying neonatal B-stress responses are subject to debate and require further studies.
